Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 20, 1998

View Archived Issues

BioCryst: Q2 1998 highlights

Medeva: half-year highlights

Genzyme division and Bayer enter into genomics agreement

MorphoSys and Pharmacia & Upjohn suspend joint research program

GR-196429 is a potent and selective agonist at melatonin receptors

Kissei reports more new agents for treating diabetic complications

More PDE4 inhibitors described by Byk Gulden

CellCept receives European approval for use in heart transplantation

Periostat licensed to Laboratoires PharmaScience for marketing in France

Merck investigators discover new glucagon antagonists

Glaxo Wellcome synthesizes improved carbapenem antibacterials

French team synthesizes novel compounds with antihypoxic/antiischemic activity

Potassium channel blockers in early research at Hoechst

GVS-111, a novel cognition-enhancing agent with a multifaceted mechanism of action

NK1 antagonist GR-205171 prevents nephrotoxicity in cisplatin-treated rats

Antiarthritic activity of cromoglicate lisetil in a model of immunologically-mediated disease

Clinical evaluation of gossypol in malignant gliomas

HMR-4902 protects against acute renal failure in rats

PGF2alpha derivative from Allergan reduces ocular hypertension in monkeys

Viagra marketing application filed in Japan

Zeldox development strategy disclosed

Key U.S. patent issued for Emitasol

U.S. patent coverage obtained for SU-5416

Russian researchers describe immunomodulatory activity of thiethazole

Available from NIH: immunotoxin for the treatment of ovarian cancer and mesotheliomas

Available from NIH: compounds for the treatment of CNS disorders

SB launches typhoid vaccine in first market

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...